Pharmacology Research & Perspectives

Pharmacology Research & Perspectives

药理学研究与展望

  • 4区 中科院分区
  • Q2 JCR分区

期刊简介

《Pharmacology Research & Perspectives》是由Wiley-Blackwell出版社于2013年创办的英文国际期刊(ISSN: 2052-1707,E-ISSN: 2052-1707),该期刊长期致力于药学领域的创新研究,主要研究方向为General Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics。作为SCIE收录期刊(JCR分区 Q2,中科院 4区),本刊采用OA开放获取模式(OA占比1%),以发表药学领域等方向的原创性研究为核心(研究类文章占比90.38%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在104篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Pharmacology Research & Perspectives审稿周期约为 20 Weeks 。该刊近年未被列入国际预警名单,年发文量约104篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 104 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 147 / 354

58.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 154 / 354

56.64%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.3 SJR:0.79 SNIP:0.786
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:General Pharmacology, Toxicology and Pharmaceutics Q1 11 / 80

86%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Neurology Q2 70 / 192

63%

期刊发文

  • Autocrine EGF and TGF-alpha promote primary and acquired resistance to ALK/c-Met kinase inhibitors in non-small-cell lung cancer

    Author: Wang, Yueqin; Zhang, Yu; Chen, Ruiying; Tian, Xin

    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1002/prp2.1047

  • MG53: A potential therapeutic target for kidney disease

    Author: Ke, Ben; Shen, Wen; Song, Jianling; Fang, Xiangdong

    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1002/prp2.1049

  • Xanthatin suppresses proliferation and tumorigenicity of glioma cells through autophagy inhibition via activation of the PI3K-Akt-mTOR pathway

    Author: Chen, Huaqing; Zhu, Tong; Huang, Xiaojie; Xu, Wenshuang; Di, Zemin; Ma, Yuyang; Xue, Min; Bi, Sixing; Shen, Yujun; Yu, Yongqiang; Shen, Yuxian; Feng, Lijie

    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1002/prp2.1041

  • Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo

    Author: Xia, Tian; Xu, Lu-Lu; Guo, Peng-Yue; Shi, Wan-Ting; Cheng, Yan-Qiong; Liu, Ai-Jun

    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2023; Vol. 11, Issue 2, pp. -. DOI: 10.1002/prp2.1064

  • Pharmacokinetic study on the effect of ligustrazine-tangeretin co-administration on the pharmacokinetics of ligustrazine and its potential mechanism in rats

    Author: Liu, Dandan; Liu, Yunjiao; Qian, Xian; Yang, Junwei; Li, Chengjian; Zhu, Lingfeng; Zhou, Jin

    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2023; Vol. 11, Issue 2, pp. -. DOI: 10.1002/prp2.1058

  • Clinical effect of different doses of ciprofol for induction of general anesthesia in elderly patients: A randomized, controlled trial

    Author: Duan, Gongchen; Lan, Haiyan; Shan, Weifeng; Wu, Yini; Xu, Qiaomin; Dong, Xiaoli; Mei, Peiyi; You, Minji; Jin, Linfei; Wu, Jimin

    Journal: PHARMACOLOGY RESEARCH & PERSPECTIVES. 2023; Vol. 11, Issue 2, pp. -. DOI: 10.1002/prp2.1066